Albert Luderer
CIK: 0001746822
Transaction Breakdown
Open Market Buys (P)2 (66.7%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (33.3%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
BNGO
Bionano Genomics, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (3 total)
- Sep 4, 2026BNGO
Bionano Genomics, Inc.
Purchase(P)Indirect4K shares at avg. $1.21$5K - Aug 21, 2026BNGO
Bionano Genomics, Inc.
Purchase(P)Indirect4K shares at avg. $1.22$5K - Jun 11, 2025BNGO
Bionano Genomics, Inc.
Award(A)DirectStock Option (Right to Buy)
2.8K shares-
1-3 of 3 transactions
About Luderer Albert
Luderer Albert (SEC CIK 0001746822) files insider reports with the SEC as Interim Chief Executive of Bionano Genomics, Inc. (BNGO).
Signal8 holds 3 ownership filings by Luderer Albert, all Form 4s, filed between Jun 12, 2025 and Sep 9, 2026. Those filings report 3 transactions, from Jun 11, 2025 to Sep 4, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Luderer Albert's filings is in SAN DIEGO, CA.
Recent filings by Luderer Albert
Other insiders filing for Bionano Genomics, Inc. (BNGO)
- Adamchak Mark, Principal Accounting Officer
- Dixon Jonathan V., General Counsel
- OLDAKOWSKI MARK, Chief Operating Officer
- Hastie Alex Reid, Chief Scientific Officer
- Chaubey Alka, CHIEF MEDICAL OFFICER
- Rajkovic Aleksandar, Director